Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12779/7063
Title: A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor
Authors: Fallacara, Anna Lucia
Zamperini, Claudio
Podolski-Renić, Ana
Dinić, Jelena
Stanković, Tijana
Stepanović, Marija
Mancini, Arianna 
Rango, Enrico 
Iovenitti, Giulia 
Molinari, Alessio
Bugli, Francesca
Sanguinetti, Maurizio
Torelli, Riccardo
Martini, Maurizio
Maccari, Laura
Valoti, Massimo
Dreassi, Elena 
Botta, Maurizio 
Pešić, Milica
Schenone, Silvia
Keywords: glioblastoma, multidrug resistance, P-gp inhibitors, Src inhibitors, in vitro ADME, pharmacokinetics, brain distribution, tolerability,
Issue Date: 2019
Project: None 
Journal: CANCERS
Description: 
174706
URI: http://hdl.handle.net/20.500.12779/7063
ISSN: 2072-6694
DOI: 10.3390/cancers11060848
Appears in Collections:Publications

Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.